Medical comments from Dr. Lewis Blevins MD. Director Center for Pituitary Disorders at University California San Francisco
From the desk of Lewis S. Blevins, Jr. M.D. PWN cofounder – Idiopathic isolated central adrenal insufficiency remains a mystery. I’ve seen several patients with this condition in my career. I first learned about it
From Lewis S. Blevins Jr., MD – Hyperplasia is an increase in the number of cells in a tissue. The cells are related, in that they may be of the same cell type, but are
From Lewis S. Blevins, Jr., MD – “This is a nice review highlighting bone disease in patients with acromegaly. One would think that bone enlargement would be associated with increased strength. That is not always
From Lewis S Blevins Jr., MD – TSH-secreting (thyrotroph) adenomas are rare and account for less than 1% of all pituitary adenomas. They usually lead to excess production of thyroid hormone (hyperthyroidism), but can also
Your physicians have determined that it is reasonably safe to discharge you from the hospital following pituitary surgery. A number of important situations may arise, however, following discharge and you should be aware of these. We are
From Lewis S Blevins Jr., MD – Twenty-four hour urine collections are often employed to estimate the production rates of various hormones. The accuracy of test results depends entirely on the proper collection of the
From Lewis S Blevins Jr., MD – The vast majority of patients with hypothyroidism can be treated with l-T4 and achieve relief of symptoms of hypothyroidism and normal T4 and T3 levels. The liver and
From Lewis S Blevins Jr., MD – There is controversy as to how to treat patients with partial hypothyroidism due to pituitary disorders and even primary hypothyroidism. After a quarter of a century of practice,
Here are a few highlights from the California Center for Pituitary Disorders at the University of California San Francisco, UCSF annual Pituitary Update Conference : Only 60% of patients with pituitary macroadenomas and vision loss have
From Lewis S Blevins Jr,. MD – My approach to the postoperative evaluation of patients with acromegaly is based on over a quarter of a century of experience evaluating and treating patients with the disorder.
From Lewis S Blevins Jr., MD – desamino d-arginine vasopressin…..in case you ever wondered. DDAVP therapy has evolved somewhat over the past quarter of a century. When I started my training one of the common
From Lewis S Blevins, Jr. MD – All too often, I see patients who come to the clinic with devastating recurrences of their pituitary tumors. For example, the accompanying MRI depicts a recurrent pituitary tumor in
From Lewis S Blevins Jr., MD – Although dopamine agonist drugs are available to treat prolactinomas I believe some patients with these tumors are probably best treated surgically. Of course, surgery should be performed by